Arrowhead Pharmaceuticals Inc (ARWR)
R&D Expenses
$198.22M
Quarterly · Period ending: · USD
ARWR R&D Expenses
Latest reported$198.22Mperiod ending
Latest reported$198.22Mperiod ending
ARWR Quarterly R&D Expenses ($0.00 → $198.22M)
Quarterly R&D Expenses
High-resolution chart · PNG
ARWR r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 198,223,000 | |
| 173,253,000 | |
| 177,203,000 | |
| 174,687,000 | |
| 162,368,000 | |
| 133,102,000 | |
| 137,002,000 | |
| 131,392,000 | |
| 148,162,000 | |
| 97,022,000 | |
| 112,640,000 | |
| 96,401,000 | |
| 91,886,000 | |
| 72,616,000 | |
| 81,409,000 | |
| 81,121,000 | |
| 69,980,000 | |
| 73,804,000 | |
| 63,595,000 | |
| 65,766,000 | |
| 59,325,000 | |
| 44,697,000 | |
| 36,555,000 | |
| 41,865,503 | |
| 31,190,734 | |
| 28,224,747 | |
| 22,262,732 | |
| 22,306,929 | |
| 18,293,261 | |
| 19,628,660 | |
| 16,399,691 | |
| 14,770,485 | |
| 10,882,412 | |
| 10,857,354 | |
| 8,431,903 | |
| 8,280,405 | |
| 6,906,016 | |
| 6,976,825 | |
| 9,527,051 | |
| 11,671,598 | |
| 9,423,195 | |
| 10,020,826 | |
| 10,338,833 | |
| 10,389,436 | |
| 7,490,400 | |
| 21,783,580 | |
| 17,744,312 | |
| 8,418,311 | |
| 6,392,200 | |
| 5,216,446 | |
| 3,133,014 | |
| 3,247,415 | |
| 1,756,527 | |
| 2,125,019 | |
| 1,576,666 | |
| 2,044,461 | |
| 1,219,236 | |
| 1,358,691 | |
| 769,074 | |
| 509,630 | |
| 365,618 | |
| 140,658 | |
| 2,261,855 | |
| 254,835 | |
| 123,343 | |
| 224,433 | |
| 277,788 | |
| 1,016,738 | |
| 2,509,675 | |
| 1,506,548 | |
| 3,888,304 | |
| 5,629,633 | |
| 3,349,423 | |
| 1,690,037 | |
| 1,664,689 | |
| 6,413,936 | |
| 8,563,401 | |
| 4,465,475 | |
| 1,487,734 | |
| 4,642,113 | |
| 1,060,892 | |
| 3,117,663 | |
| 2,643,279 | |
| 1,258,843 | |
| 1,344,781 | |
| 439,038 | |
| 647,906 | |
| 358,709 | |
| 232,235 | |
| 141,660 | |
| 60,750 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |